Interim Report Q2 – April – June, 2022 Redsense Medical AB (publ)
April – June 2022 · Net sales amounted to kSEK 1,927 (1,479), an increase by 30.3 percent. · Operating loss, EBIT amounted to kSEK 2,428 (2,874). · Result after tax amounted to kSEK -2,137 (-3,221). · Earnings per share was SEK -0.15 (-0.23) before and after dilution. January – June 2022 · Net sales amounted to kSEK 5,054 (2,164), an increase by 134 percent. · Operating loss, EBIT amounted to kSEK 4,503 (6,024). · Result after tax amounted to kSEK -3,687 (-4,710). · Earnings per share was SEK -0.26 (-034) before and after dilution. · Net cash at June 30 was